Hospital
Owasso Medical Facility, INC
Owasso Medical Facility, INC was paid $3.35M by Medicaid between Jan 2018 and Nov 2024, across 31 billing codes. Its largest line is 99283, emergency room visit (moderate) — 54% of everything it billed.
33Billing provider infoOWASSO MEDICAL FACILITY, INC
OWASSO, OK 74055
OWASSO, OK 74055
33aNPI1144231432assigned 08/11/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$3.35M
24GClaims35,996
24DCodes billed31
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other General Acute Care Hospital providers in Oklahoma
Rank by total paid#42 of 75
Median peer was paid$3.66M
This provider vs. median0.9×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,977 | $319K | |
| 2019 | 3,096 | $315K | |
| 2020 | 1,877 | $198K | |
| 2021 | 5,337 | $516K | |
| 2022 | 9,832 | $858K | |
| 2023 | 9,799 | $871K | |
| 2024incomplete | 3,078 | $276K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 54% | 10,828 | 10,754 | $1.80M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 16% | 2,049 | 2,007 | $530K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 11% | 1,038 | 1,029 | $384K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 9.1% | 2,158 | 2,128 | $304K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.9% | 981 | 978 | $96K |
| 80053 | Comprehensive metabolic panel | 1.7% | 4,236 | 4,149 | $58K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 5,047 | 4,941 | $32K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,031 | 995 | $31K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 2,060 | 1,022 | $29K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 531 | 529 | $25K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 157 | 156 | $11K |
| 83605 | <1% | 1,116 | 1,018 | $11K |
19 more codes
| 71045 | Radiologic examination, chest; single view | <1% | 615 | $8K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 39 | $7K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 400 | $6K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 196 | $6K |
| 81025 | <1% | 531 | $4K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 123 | $3K |
| 81003 | <1% | 346 | $2K | |
| 83690 | <1% | 416 | $2K | |
| 81001 | <1% | 788 | $2K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 36 | $2K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 283 | $1K |
| 84484 | <1% | 82 | $853.93 | |
| 87807 | <1% | 57 | $672.03 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 602 | $231.80 |
| 36415 | Collection of venous blood by venipuncture | <1% | 65 | $230.91 |
| 83735 | <1% | 13 | $77.48 | |
| J7030 | Infusion, normal saline solution , 1000 cc | 0% | 108 | $0.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 12 | $0.00 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 52 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPHILLIPS, DAVID (CHIEF EXECUTIVE OFFICER)
Parent organizationST. JOHN HEALTH SYSTEM
| Provider | Location | Paid |
|---|---|---|
| ST John Sapulpa, INC. | Sapulpa, OK | $6.85M |
| Harrison Community Hospital, INC. | Cadiz, OH | $4.66M |
| Barnesville Hospital Association, INC. | Barnesville, OH | $3.14M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.